دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Dengue: the threat to health now and in the future
doi : 10.1016/S0140-6736(24)01542-3
Volume 404, Issue 10450, 27 July–2 August 2024, Page 311
Enhancing the treatment landscape: PET-guided BrECADD for advanced-stage, classical Hodgkin lymphoma
Andrew M Evens a
CD22 CAR T-cell therapy: new hope for patients with large B-cell lymphoma
Maria-Luisa Schubert a, Peter Dreger a
Self-guided digital acceptance and commitment therapy as a treatment option for fibromyalgia
Guilherme Torres Vilarino
Unlocking the power of NHS research: a priority for the new UK Government
Andrew Morris a
The CONCORD–Lancet Global Commission on Cancer
Claudia Allemani a, Gulnar Azevedo e Silva b, Prashant Mathur c, Michel P Coleman a
Transparent and complete reporting of surrogate endpoints in trials: the SPIRIT-Surrogate and CONSORT-Surrogate extensions
Anthony Muchai Manyara a b, Oriana Ciani c, Rod S Taylor a d, SPIRIT-Surrogate and CONSORT-Surrogate Project team and Consensus Group
Charges brought in Brazilian COVID-19 malpractice case
Marcia Triunfol
AbbVie to face potentially groundbreaking case over Humira
Ferry Biedermann
Kathleen Maletic Neuzil: new Fogarty International Center leader
Udani Samarasekera
Tackling Japan's population crisis by improving the childcare environment
Aiju Koyama a, Akihiko Ozaki b, Arinobu Hori c, Tetsuya Tanimoto d
Peer learning in immunisation programmes
Abdu A Adamu a, Duduzile Ndwandwe b, Rabiu I Jalo c, Modjirom Ndoutabe a, Charles S Wiysonge a b d
CAR T-cell perspectives in lupus
Elisa Gremese a, Dario Bruno a, Gianfranco Ferraccioli a
CAR T-cell perspectives in lupus – Authors' reply
Georg Schett a c, Andreas Mackensen b c, Dimitrios Mougiakakos d e
Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial
Yakup Ergun a
Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial
Yilin Gu a
Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial
Andrea Messori a
Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial
Kayo Harada a, Akihiko Ozaki b c, Tetsuya Tanimoto c d
Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial – Authors' reply
Hope S Rugo a, Aditya Bardia b, Sara Tolaney c
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
Prof Peter Borchmann MD a b c d , Justin Ferdinandus MD a b c d , Gundolf Schneider MA a b c d , Alden Moccia MD e f , Prof Richard Greil MD g h i , Prof Mark Hertzberg MD j k , Valdete Schaub MD l , Prof Andreas Hüttmann MD m , Prof Felix Keil MD n , Prof Judith Dierlamm MD o , Mathias Hänel MD p , Prof Urban Novak MD e q , Julia Meissner MD r , Andreas Zimmermann MD s , Prof Stephan Mathas MD t u v w , Prof Josée M Zijlstra MD PhD x , Alexander Fosså MD y z , Prof Andreas Viardot MD aa , Prof Bernd Hertenstein MD ab , Sonja Martin MD ac … Prof Volker Diehl MD a b c d
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study
Matthew J Frank MD a c *, John H Baird MD d *, Anne Marijn Kramer MD a c e *, Hrishikesh K Srinagesh MD a, Shabnum Patel PhD c, Annie Kathleen Brown MS c, Jean S Oak MD f, Sheren F Younes PhD f, Yasodha Natkunam MD f, Mark P Hamilton MD a c, Yi-Jiun Su MD a g, Neha Agarwal MS a, Harshini Chinnasamy MS c, Emily Egeler PhD c, Sharon Mavroukakis MS c, Steven A Feldman PhD c, Bita Sahaf PhD c, Prof Crystal L Mackall MD a b c, Lori Muffly MD c, Prof David B Miklos MD a c…Ramya Tunuguntla
Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): a phase 3, multicentre, randomised controlled trial
R Michael Gendreau MD PhD a , Prof Lance M McCracken PhD b , Prof David A Williams PhD c , Juan V Luciano PhD d e f , Yifei Dai PhD g , Nicolette Vega BA g , Zunera Ghalib BS g , Kristen Guthrie BS g , Allison C Kraus MA g , Michael J Rosenbluth PhD g , Ben Vaughn MS h , Jennifer M Zomnir MD i , Dana Reddy MD j , Prof Andrea L Chadwick MD k , Prof Daniel J Clauw MD c , Prof Lesley M Arnold MD l
A visual diagnosis of phaeochromocytoma crisis characterised by cyclic fluctuations of blood pressure: be on the look-out for rapid changes
Martin Wernhart MD a, Clemens Wiesinger MD b, Martin Windpessl MD c, Lisa Madl-Liebenberger MD a, Elisabeth Lassnig MD a, Ronald K Binder MD a, Thomas Weber MD a
Infective endocarditis
Mingfang Li MD a, Joon Bum Kim MD b, B K S Sastry MD c, Prof Minglong Chen MD a
Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment
Prof Torsten Zuberbier MD a b, Luis Felipe Ensina MD c, Ana Giménez-Arnau MD d, Clive Grattan MD e, Emek Kocatürk MD a b f, Kanokvalai Kulthanan MD g, Pavel Kolkhir MD a b †, Marcus Maurer MD a b â€
